As the Dow Jones index took a nosedive, U.S. stocks experienced a tumultuous Tuesday, with over 200 points shaved off the index.
In a delightful twist, BlackBerry Limited BB soared, defying the market slump with a sharp uptick.
This surge came on the heels of a groundbreaking collaboration between BlackBerry and Advanced Micro Devices, Inc. AMD. The partnership aims to invigorate next-gen robotic systems, promising unparalleled speed and precision.
Amidst this favorable backdrop, BlackBerry’s shares catapulted 9% to $3.1340, much to the joy of investors.
The exuberance was not limited to BlackBerry alone. Other major players also joined the winning streak on Tuesday.
- Nurix Therapeutics, Inc. NRIX leaped a staggering 19% to $16.42. Nurix Therapeutics showcased its prowess by extending a strategic alliance with Sanofi to develop innovative protein degraders.
- Taysha Gene Therapies, Inc. TSHA witnessed a commendable 14% surge to $3.0650 after Piper Sandler initiated coverage, adorned with an Overweight rating and a $9 price target.
- Lyell Immunopharma, Inc. LYEL notched an impressive 10.5% increase, reaching $2.42.
- Wheels Up Experience Inc. UP surged by 10.3% to $3.00, adding to the bullish sentiment of the day.
- XPeng Inc. XPEV also embraced the positive trend, climbing 8.7% to $8.02 in a compelling display of market strength.
- Revance Therapeutics, Inc. RVNC posted a robust gain of 8.6%, closing at $4.8350.
- Moderna, Inc. MRNA surged 8.3% to $113.81, riding the positive wave in the market.
- NIO Inc. NIO saw its shares elevate by 7.7% to $4.7050, buoyed by the filing of its 2023 annual report on Form 20-F.
- Absci Corporation ABSI recorded a solid 7.4% growth, reaching $6.06.
- Hudbay Minerals Inc. HBM surged by 7.2% to $8.01, spurred by B of A Securities’ upgrade from Neutral to Buy.
- Coeur Mining, Inc. CDE experienced a 7% climb to $5.06. Roth MKM analyst Joe Reagor bestowed a Buy rating on Coeur Mining, setting a price target of $5.4.
- Bilibili Inc. BILI appreciated by 5.6% to $11.70, echoing the overall positive sentiment in the market.
- Maravai LifeSciences Holdings, Inc. MRVI witnessed a 5.5% surge to $8.30, showcasing robust market performance.
- Tesla, Inc. TSLA closed the day with a 2.3% increase to $176.93. While Goldman Sachs analyst Mark Delaney maintained a Neutral stance and lowered the price target, Morgan Stanley analyst Adam Jonas remained optimistic with an Overweight rating and retained a $310 price target.
Curious about the drama that unfolded in the world of hostile takeovers? Discover more about Jim Cramer’s rollercoaster of emotions and market insights here.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
